1994
DOI: 10.1097/00007890-199401001-00013
|View full text |Cite
|
Sign up to set email alerts
|

The Use of Percutaneous Transluminal Angioplasty in Hepatic Artery Stenosis After Transplantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
35
0

Year Published

1999
1999
2017
2017

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 61 publications
(35 citation statements)
references
References 0 publications
0
35
0
Order By: Relevance
“…6 Various diagnostic modalities and treatments for HAT have been reported in the literature. [1][2][3][4][5][6][7][8][9][10][11][12][13][14] The optimum diagnostic tool and treatment depends on the condition of the patient, viability of the liver, availability of specific medical expertise, and availability of organs for transplantation. Retransplantation, surgical revascularization, thrombolysis, percutaneous transluminal balloon angioplasty, or hyperbaric oxygen therapy are the therapeutic options described.…”
mentioning
confidence: 99%
“…6 Various diagnostic modalities and treatments for HAT have been reported in the literature. [1][2][3][4][5][6][7][8][9][10][11][12][13][14] The optimum diagnostic tool and treatment depends on the condition of the patient, viability of the liver, availability of specific medical expertise, and availability of organs for transplantation. Retransplantation, surgical revascularization, thrombolysis, percutaneous transluminal balloon angioplasty, or hyperbaric oxygen therapy are the therapeutic options described.…”
mentioning
confidence: 99%
“…CDI has become a pivotal imaging modality in the elucidation of hepatic dysfunction. It can be used as a sensitive method for preliminary diagnosis of HAS and therefore timely intervention before the onset of irreversible biliary damage and even hepatic parenchymal infarction [1,[13][14][15] . However, an angiogram, the diagnostic gold standard, must be performed for accurate diagnosis and treatment of HAS.…”
Section: Discussionmentioning
confidence: 99%
“…It was less than 67% reported by Orons et al [15] . Treatment of HAS before the development of biliary necrosis has a marked impact on the clinical outcome of patients with HAS [1,[13][14][15] . Orons et al [15] demonstrated that patients showing poor liver function test results at presentation always required retransplantation regardless of the success or failure of PTA.…”
Section: Discussionmentioning
confidence: 99%
“…Delayed complications (i.e., HAT) within 30 d of PTA occurred in 5% of cases, yielding a total complication rate of 12% and 12% total failed attempts without consequences. In this treatment modality, very different rates of restenosis have been reported from no restenosis to rates as high as 75% [60,63,64,67,68] . Denys et al [60] (2002) reported a low rate of HAT among 13 HAS patients treated by HA stent placement, which may be attributed to anticoagulation and/or antiplatelet regimens that were routinely given to their patients [52,60] .…”
Section: Therapeutic Managementmentioning
confidence: 99%